Sudarshan Chemical Industries Limited — Investor Meet, 12-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Sudarshan Chemical Industries shared its Q3 & 9M FY26 investor presentation. Q3 consolidated revenue stood at ₹1,479 Cr, down from ₹1,683 Cr in Q2, with Adjusted EBITDA at ₹40 Cr (1.9%). PBT was negative ₹123 Cr, impacted by broad market softness and a new labor code. For 9M FY26, revenue was ₹6,997 Cr and Adjusted EBITDA ₹322 Cr (4.6%). Management notes signs of recovery, easing destocking, and strong integration progress. Value capture efforts are expected to boost profitability. The company foresees positive Q4 business EBITDA for the acquired group, while inventory reduction for cash flow may temporarily impact reported EBITDA. Outlook is cautiously optimistic on synergy benefits.